Doxorubicin‐Induced Cardiotoxicity: Comprehensive Pathway Insights and Advanced Preclinical Therapeutics
Journal of Applied Toxicology · 2026-06 · 46 (6) · 1801-1837
DOI: 10.1002/jat.70131 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Applied Toxicology, online erschienen am 11.03.2026. Verfasst von Seema Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shri Vaishnav Vidyapeeth Vishwavidyalaya, Indore, Madhya Pradesh, India. Hauptthemen laut MEDLINE: Cardiotoxicity, Doxorubicin, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 451 Literaturangaben.
Abstract (Originalsprache)
Doxorubicin, a secondary metabolite of Streptomyces peucetius var. caesius and a member of the anthracycline family, exerts anticancer effects via DNA intercalation and topoisomerase II inhibition in tumor cells. However, its clinical application is limited by dose‐dependent and cumulative cardiotoxicity. The mechanisms underlying doxorubicin‐induced cardiotoxicity (DIC) include oxidative stress, lipid peroxidation, mitochondrial dysfunction, calcium dysregulation, disrupted iron homeostasis, nitric oxide release, and inflammatory mediator production. Emerging evidence highlights autophagy dysregulation, with doxorubicin upregulating cardiac autophagy by suppressing GATA4 and ribosomal protein S6 kinase beta‐1(S6K1). Mitochondria‐dependent ferroptosis also plays a significant role, driven by downregulation of glutathione peroxidase 4 (GPX4), lipid peroxidation via DOX‐Fe 2+ complexes, and dysregulated iron metabolism. Additionally, DOX triggers pyroptosis in cardiomyocytes, involving proteins such as NLRP3 (NOD‐, LRR‐, and pyrin domain‐containing protein 3), caspase‐3, and gasdermin D (GSDMD). Epigenetic alterations, including DNA hypomethylation (via downregulation of DNMT1 (DNA (cytosine‐5)‐methyltransferase 1), changes in microRNA levels (e.g., upregulation of miR‐520h targeting HDAC19 (histone deacetylase 1), and histone deacetylase inhibition, exacerbate cardiac damage. Recent studies also emphasize the role of gut microbiota in doxorubicin‐induced cardiotoxicity. Doxorubicin induces dysbiosis, leading to cardiomyocyte apoptosis and elevated myocardial enzyme levels. Interventions such as dietary modifications, fecal microbiota transplantation, probiotics, and natural compounds like glabridin and emodin show promise. Glabridin reduces inflammation by modulating colonic macrophage polarization, while emodin inhibits ferroptosis via gut microbiota remodeling mediated by Nrf2. This review explores oxidative stress, lipid peroxidation, ferroptosis, apoptosis, inflammation, autophagy, epigenetics, and gut microbiota in DIC, alongside promising pharmacological strategies to mitigate its effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Shri Vaishnav Vidyapeeth Vishwavidyalaya, Indore, Madhya Pradesh, India.
- Department of Pharmacy, SAGE University, Bhopal, Madhya Pradesh, India.
- Patanjali Research Foundation Trust, Haridwar, Uttarakhand, India.
- Department of Pharmacology, Yenepoya Pharmacy College and Research Centre, Mangalore, Karnataka, India.
ORCID-Profile: Seema Sharma, Megha Parashar, Kanhaiya Lal, Manoj Naik, Sampat Singh Tanwar
Zitieren
APA
Sharma, S., Parashar, M., Lal, K., Naik, M., & Tanwar, S. S. (2026). Doxorubicin‐Induced Cardiotoxicity: Comprehensive Pathway Insights and Advanced Preclinical Therapeutics. Journal of Applied Toxicology, 46(6), 1801-1837. https://doi.org/10.1002/jat.70131
Vancouver
Sharma S, Parashar M, Lal K, Naik M, Tanwar SS. Doxorubicin‐Induced Cardiotoxicity: Comprehensive Pathway Insights and Advanced Preclinical Therapeutics. Journal of Applied Toxicology. 2026;46(6):1801-1837. doi:10.1002/jat.70131
BibTeX
@article{Sharma2026,
author = {Sharma, Seema and Parashar, Megha and Lal, Kanhaiya and Naik, Manoj and Tanwar, Sampat Singh},
title = {Doxorubicin‐Induced Cardiotoxicity: Comprehensive Pathway Insights and Advanced Preclinical Therapeutics},
journal = {Journal of Applied Toxicology},
year = {2026},
volume = {46},
number = {6},
pages = {1801--1837},
doi = {10.1002/jat.70131}
}
EUVIMED